Targeting hyperinflammation in infection can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?

Angela McBride
, Puja Mehta
, Laura Rivino
, Athimalaipet V. Ramanan
, Sophie Yacoub

Brighton and Sussex Medical School
University of Oxford
University College London
University College London Hospitals NHS Foundation Trust
University of Bristol
University Hospitals Bristol and Weston NHS Foundation Trust

Research output: Contribution to journal › Comment/debate

11 Citations (Scopus)

Original language	English
Pages (from-to)	e277-e278
Journal	The Lancet Microbe
Volume	2
Issue number	7
DOIs	https://doi.org/10.1016/S2666-5247(21)00087-2
Publication status	Published - 29 Jul 2021
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S2666-5247(21)00087-2

Cite this

@article{c893eb48064e4083adb35f6646744280,

title = "Targeting hyperinflammation in infection can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?",

author = "Angela McBride and Puja Mehta and Laura Rivino and Ramanan, \{Athimalaipet V.\} and Sophie Yacoub",

year = "2021",

month = jul,

day = "29",

doi = "10.1016/S2666-5247(21)00087-2",

language = "English",

volume = "2",

pages = "e277--e278",

journal = "The Lancet Microbe",

issn = "2666-5247",

publisher = "Elsevier Ltd",

number = "7",

}

TY - JOUR

T1 - Targeting hyperinflammation in infection can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?

AU - McBride, Angela

AU - Mehta, Puja

AU - Rivino, Laura

AU - Ramanan, Athimalaipet V.

AU - Yacoub, Sophie

PY - 2021/7/29

Y1 - 2021/7/29

U2 - 10.1016/S2666-5247(21)00087-2

DO - 10.1016/S2666-5247(21)00087-2

M3 - Comment/debate

AN - SCOPUS:85107130769

SN - 2666-5247

VL - 2

SP - e277-e278

JO - The Lancet Microbe

JF - The Lancet Microbe

IS - 7

ER -